Kelly Shi
Stock Analyst at Jefferies
(2.96)
# 1,313
Out of 5,127 analysts
34
Total ratings
45.45%
Success rate
11.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $6.56 | +37.20% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $79.49 | +53.48% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $72.14 | +6.74% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $148.55 | -0.37% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $37.77 | -25.87% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $15.25 | +188.52% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.28 | +138.85% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $7.69 | +576.20% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.45 | +156.88% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $23.55 | -19.32% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $224.19 | -12.57% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $3.89 | +439.85% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.32 | +73.55% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.01 | +198.51% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $100.05 | -19.04% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.08 | +66.03% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.60 | +1,284.62% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $15.62 | +2.43% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $19.57 | +2.22% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.13 | +5,958.91% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.96 | +247.59% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.68 | +907.46% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $2.98 | +1,007.38% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.56
Upside: +37.20%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $79.49
Upside: +53.48%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $72.14
Upside: +6.74%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $148.55
Upside: -0.37%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $37.77
Upside: -25.87%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $15.25
Upside: +188.52%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.28
Upside: +138.85%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $7.69
Upside: +576.20%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.45
Upside: +156.88%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $23.55
Upside: -19.32%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $224.19
Upside: -12.57%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $3.89
Upside: +439.85%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.32
Upside: +73.55%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.01
Upside: +198.51%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $100.05
Upside: -19.04%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $21.08
Upside: +66.03%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.60
Upside: +1,284.62%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $15.62
Upside: +2.43%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $19.57
Upside: +2.22%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.13
Upside: +5,958.91%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.96
Upside: +247.59%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.68
Upside: +907.46%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $2.98
Upside: +1,007.38%